1. Home
  2. FFBC vs DNLI Comparison

FFBC vs DNLI Comparison

Compare FFBC & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Financial Bancorp.

FFBC

First Financial Bancorp.

HOLD

Current Price

$30.80

Market Cap

2.7B

Sector

Finance

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$20.04

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FFBC
DNLI
Founded
1863
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.0B
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
FFBC
DNLI
Price
$30.80
$20.04
Analyst Decision
Buy
Strong Buy
Analyst Count
8
14
Target Price
$30.71
$34.33
AVG Volume (30 Days)
709.7K
1.2M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
3.25%
N/A
EPS Growth
10.83
N/A
EPS
2.66
N/A
Revenue
N/A
N/A
Revenue This Year
$27.67
N/A
Revenue Next Year
$4.58
$408.85
P/E Ratio
$11.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$22.63
$12.58
52 Week High
$31.38
$23.77

Technical Indicators

Market Signals
Indicator
FFBC
DNLI
Relative Strength Index (RSI) 68.26 49.30
Support Level $23.31 $18.86
Resistance Level $31.38 $20.71
Average True Range (ATR) 0.65 0.85
MACD 0.14 -0.01
Stochastic Oscillator 79.38 35.74

Price Performance

Historical Comparison
FFBC
DNLI

About FFBC First Financial Bancorp.

First Financial Bancorp is a mid-sized, regional bank holding company. It engages in the business of commercial banking and other banking and banking-related activities through its subsidiary. The range of banking services provided to individuals and businesses includes commercial lending, real estate lending and consumer financing. Real estate loans are loans secured by a mortgage lien on the real property of the borrower, which may either be residential property or commercial property. In addition, it offers deposit products that include interest-bearing and noninterest-bearing accounts, time deposits and cash management services for commercial customers. A full range of trust and wealth management services is also provided through First Financial's Wealth Management line of business.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: